Shinjan Patra
All India Institute of Medical Sciences, Kalyani, All India Institute of Medical Sciences, Nagpur, All India Institute of Medical Sciences Jodhpur
About
I am Dr. Shinjan Patra, currently working as an Assistant Professor in the Department of Endocrinology and Metabolism in the prestigious All India Institute of Medical Sciences in Kalyani. I have always been passionate about working in the field of endocrinology and currently I am looking forward to continuing this passion. I am trying to excel in the academic and research fields My current research interests are Bone mineral density and body composition analysis in various non-bone mineral diseases like acromegaly, type 2 diabetes, pheochromocytoma and primary aldosteronism.
Employment
-
All India Institute of Medical Sciences, Kalyani Assistant Professor2025 - Present
-
All India Institute of Medical Sciences, Nagpur Assistant Professor2023 - 2025
-
All India Institute of Medical Sciences Jodhpur Senior Resident2020 - 2023
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (45)
- Significant improvement following intravenous zoledronate therapy in Bruck syndrome 2 due to a rare PLOD2 gene variant Save
- Technology and Obesity: A Year in Review Save
- Efficacy and Safety of Once-Weekly IcoSema in Adults With Type 2 Diabetes: A Systematic Review and Meta-Analysis Save
- Mucopolysaccharidosis type IVA (Morquio A) in twins masquerading as distal renal tubular acidosis Save
- Precocious puberty in male with hypertension and hypokalemia; a definite diagnostic clue for 11β hydroxylase deficiency CAH Save
- A novel SGMS2 mutation associated with high bone mass; description of an affected family with recurrent fragility fractures Save
- Renal effects and safety of tirzepatide in subjects with and without diabetes: A systematic review and meta-analysis Save
- Biochemically ‘active’ pheochromocytoma can be clinically ‘silent’ Save
- Efficacy and Safety of Levoketoconazole in Managing Cushing’s Syndrome: A Systematic Review Save
- Role of anagliptin, a dipeptidyl peptidase-4 inhibitor, in managing type 2 diabetes: A systematic review and meta-analysis Save